Mon, December 6, 2021

Salveen Richter Initiated (BIIB) at Hold and Held Target at $271 on, Dec 6th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-271-on-dec-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Salveen Richter of Goldman Sachs, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $271 on, Dec 6th, 2021.

Salveen has made no other calls on BIIB in the last 4 months.



There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 4 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $270 on, Tuesday, October 26th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021


These are the ratings of the 8 analyists that currently disagree with Salveen


  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $390 on, Thursday, October 21st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $440 on, Thursday, October 21st, 2021
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $386 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021